|
|
|
 |
|
製品情報 - Active Pharma Ingredients(API)
|
Verteporfin(DB00460)
| カタログ : |
C14327 |
| 製品の名前: |
Verteporfin(DB00460) |
| 同義語: |
Verteporphin;Visudyne;CL 318,952;Benzoporphyrin D;Bpd-MA;AIDS350621;AIDS-350621 |
| 化学の名前: |
trans-3,4-Dicarboxy-4,4a-dihydro-4a,8,14,19-tetramethyl-18-vinyl-23H,25H-benzo(b)porphine-9,13-dipropionic acid 3,4,9-trimethyl ester;9-methyl (I) and 13-methyl (II)trans-(±)- 18-ethenyl- 4,4a-dihydro-3,4 -bis(methoxycarbonyl)- 4a,8,14,19-tetramethyl- 23H,25H-benzo[b]porphine- 9,13- dipropanoate |
| CASナンバー : |
129497-78-5 |
| 構成 : |
|
| 分子式: |
C41H42N4O8 |
| 分子量: |
718.79 |
| 純度: |
>99% |
| 使い方: |
Verteporfin (Visudyne) is a benzoporphyrin derivative and is a medication used as a photosensitizer for photodynamic therapy to eliminate the abnormal blood vessels in the eye associated with conditions such as the wet form of macular degeneration. Verteporfin accumulates in these abnormal blood vessels and, when stimulated by nonthermal red light with a wavelength of 693 nm in the presence of oxygen, produces highly reactive short-lived singlet oxygen and other reactive oxygen radicals, resulting in local damage to the endothelium and blockage of the vessels. Verteporfin is also used off-label for the treatment of central serous retinopathy. |
|
| 制品、有效に関する特許保護を売却せず、国家、売却こうした製品の特許侵害金人で、それは私たちの知らない特許の情况は全ての国、特許侵害責任は、十分に理解できるをバイヤーのリスクを高める. |
|
|
